£132.76

Springer Diagnosis and Treatment of Parkinson’s Disease ― State of the Art: 56 (Journal of Neural Transmission. Supplementa, 56)

Price data last checked 19 day(s) ago - will refresh soon

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

It has never been this cheap. We have no record of a lower price.

£133 today · cheaper than every other day in the last 3 months

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 72 days • 72 data points (No recent data available)

Historical
Generating forecast...
£135.38 £132.50 £133.13 £133.76 £134.38 £135.01 £135.64 28 March 2026 14 April 2026 02 May 2026 20 May 2026 07 June 2026

Price Distribution

Price distribution over 72 days • 2 price levels

Days at Price
Current Price
3 days · current 69 days 0 17 35 52 69 £133 £135 Days at Price

Price Analysis

Most common price: £135 (69 days, 95.8%)

Price range: £133 - £135

Price levels: 2 different prices over 72 days

Description

Expert clinicians and basic scientists with a special interest in Parkinson’s disease review the current state of science and clinical therapeutics of the disease. Therefore these articles represent an authorative review of the current state of knowledge regarding preclinical course and symptomatology, subtypes with their impact on the pathology, genetic alterations, novel mechanisms of neuronal cell death, diagnostic tools and old and novel therapeutic approaches with respect to neuroprotection and neuroregeneration in Parkinson’s disease. Particular emphasis has been placed on a novel antiparkinsonian drug called budipine with various modes of action also influencing altered non dopaminergic systems in Parkinson’s disease. It is evident, that many questions on the cause, course and treatment of Parkinson’s disease are still unanswered and therefore the ideal way to treat a parkinsonian patient remains to be defined.

Product Specifications

Format
hardcover
Domain
Amazon UK
Release Date
11 May 1999
Listed Since
08 December 2006

Barcode

No barcode data available

Similar Products You Might Like

Parkinson's Disease: Current and Future Therapeutics and Clinical Trials
83% match

Parkinson's Disease: Current and Future Therapeutics and Clinical Trials

Cambridge University Press

£94.61 24 May 2026
Pharmacological Foundations of Parkinson’s Disease: From Mechanisms to Clinical Practice
81% match

Pharmacological Foundations of Parkinson’s Disease: From Mechanisms to Clinical Practice

Academic Press

£137.99 20 May 2026
Malattia di Parkinson e parkinsonismi: La prospettiva delle neuroscienze cognitive
80% match

Malattia di Parkinson e parkinsonismi: La prospettiva delle neuroscienze cognitive

Springer

£60.49 05 Jun 2026
Systems Biology of Parkinson's Disease
80% match

Systems Biology of Parkinson's Disease

Springer

£107.41 24 May 2026
Handbook of Non-Motor Symptoms in Parkinson's Disease
79% match

Handbook of Non-Motor Symptoms in Parkinson's Disease

Springer

£39.73 31 May 2026
Atypical Parkinsonian Disorders: Clinical and Research Aspects (Current Clinical Neurology)
79% match

Atypical Parkinsonian Disorders: Clinical and Research Aspects (Current Clinical Neurology)

Humana

£50.21 20 May 2026
Programmed Cells from Basic Neuroscience to Therapy: 20 (Research and Perspectives in Neurosciences, 20)
79% match

Programmed Cells from Basic Neuroscience to Therapy: 20 (Research and Perspectives in Neurosciences, 20)

Springer

£106.91 11 Jun 2026
78% match

Advanced and Integrative Therapeutic Strategies in Parkinson’s Disease Management

Academic Press

£133.99 22 May 2026
Emerging Neurobiology of Antidepressant Treatments: 66 (Current Topics in Behavioral Neurosciences, 66)
78% match

Emerging Neurobiology of Antidepressant Treatments: 66 (Current Topics in Behavioral Neurosciences, 66)

Springer

£71.91 19 May 2026
Neuropsychiatric Disorders
78% match

Neuropsychiatric Disorders

Springer

£107.98 27 May 2026
Neurodegenerative Diseases: Integrative PPPM Approach as the Medicine of the Future: 2 (Advances in Predictive, Preventive and Personalised Medicine, 2)
78% match

Neurodegenerative Diseases: Integrative PPPM Approach as the Medicine of the Future: 2 (Advances in Predictive, Preventive and Personalised Medicine, 2)

Springer

£108.75 14 Jun 2026
Behavioral Neurobiology of Huntington's Disease and Parkinson's Disease: 22 (Current Topics in Behavioral Neurosciences, 22)
77% match

Behavioral Neurobiology of Huntington's Disease and Parkinson's Disease: 22 (Current Topics in Behavioral Neurosciences, 22)

Springer

£76.38 06 Jun 2026
Parkinson’s Disease: Neurophysiological, Clinical, and Related Aspects: 90 (Advances in Experimental Medicine and Biology, 90)
77% match

Parkinson’s Disease: Neurophysiological, Clinical, and Related Aspects: 90 (Advances in Experimental Medicine and Biology, 90)

Springer

£76.38 03 Jun 2026
Neurodegenerative Diseases: 6 (Topics in Medicinal Chemistry, 6)
77% match

Neurodegenerative Diseases: 6 (Topics in Medicinal Chemistry, 6)

Springer

£107.63 26 May 2026
Psych Cog Disorders Parkinson Dis
77% match

Psych Cog Disorders Parkinson Dis

Cambridge University Press

£50.45 06 Jun 2026
Neurodegenerative Diseases: Clinical Aspects, Molecular Genetics and Biomarkers
77% match

Neurodegenerative Diseases: Clinical Aspects, Molecular Genetics and Biomarkers

Springer

£117.61 11 May 2026
Nonmotor Parkinson's: The Hidden Face: The Many Hidden Faces (Volume 133) (International Review of Neurobiology, Volume 133)
77% match

Nonmotor Parkinson's: The Hidden Face: The Many Hidden Faces (Volume 133) (International Review of Neurobiology, Volume 133)

Academic Press

£156.19 19 May 2026
Neurodegenerative Diseases: Integrative PPPM Approach as the Medicine of the Future: 2 (Advances in Predictive, Preventive and Personalised Medicine, 2)
77% match

Neurodegenerative Diseases: Integrative PPPM Approach as the Medicine of the Future: 2 (Advances in Predictive, Preventive and Personalised Medicine, 2)

Springer

£111.83 26 May 2026
Leucine-Rich Repeat Kinase 2 (LRRK2): 14 (Advances in Neurobiology, 14)
77% match

Leucine-Rich Repeat Kinase 2 (LRRK2): 14 (Advances in Neurobiology, 14)

Springer

£107.98 25 May 2026
Ageing and Dementia: Current And Future Concepts: 62 (Journal of Neural Transmission. Supplementa, 62)
77% match

Ageing and Dementia: Current And Future Concepts: 62 (Journal of Neural Transmission. Supplementa, 62)

Springer

£165.20 01 Jun 2026
Neurodegenerative Disorders: A Clinical Guide
77% match

Neurodegenerative Disorders: A Clinical Guide

Springer

£60.42 26 May 2026
Molecular Biology of Neuropsychiatric Disorders: 23 (Nucleic Acids and Molecular Biology, 23)
77% match

Molecular Biology of Neuropsychiatric Disorders: 23 (Nucleic Acids and Molecular Biology, 23)

Springer

£141.23 24 May 2026
Psychopharmacology of the Developmental Disabilities (Disorders of Human Learning, Behavior, and Communication)
76% match

Psychopharmacology of the Developmental Disabilities (Disorders of Human Learning, Behavior, and Communication)

Springer

£76.38 01 Jun 2026
Pathogenesis of Neurodegenerative Disorders (Contemporary Neuroscience)
76% match

Pathogenesis of Neurodegenerative Disorders (Contemporary Neuroscience)

Humana

£143.49 24 May 2026